{"id":102,"date":"2020-04-23T06:46:09","date_gmt":"2020-04-23T06:46:09","guid":{"rendered":"https:\/\/nclinnovations.org\/covid19monitor\/?p=102"},"modified":"2020-05-12T05:36:27","modified_gmt":"2020-05-12T05:36:27","slug":"14-april-2020-umifenovir-arbidol-shorter-duration-of-positive-rna-test","status":"publish","type":"post","link":"https:\/\/nclinnovations.org\/covid19monitor\/14-april-2020-umifenovir-arbidol-shorter-duration-of-positive-rna-test\/","title":{"rendered":"(14 April 2020)- Umifenovir (Arbidol)- shorter duration of positive RNA test"},"content":{"rendered":"<div class=\"boldgrid-section\">\n<div class=\"container\">\n<div class=\"row\">\n<div class=\"col-md-12 col-xs-12 col-sm-12\">\n<p class=\"\">Arbidol monotherapy is superior to lopinavir\/ritonavir in treating COVID-19<\/p>\n<p class=\"\">https:\/\/www.journalofinfection.com\/article\/S0163-4453(20)30188-2\/pdf<\/p>\n<p class=\"\" style=\"text-align: left;\">In the present study, the authors anayzed&nbsp; the efficacy and safety of lopinavir\/ritonavir and arbidol monotherapy in patients with COVID-19. On day 14 after the admission, no viral load was detected in the arbidol group, but the viral load was found in 44.1% of the patients treated with lopinavir\/ritonavir. Furthermore, no apparent side effects were found in both groups. Data from the study indicates that arbidol monotherapy may be superior to lopinavir\/ritonavir in treating COVID-19<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Arbidol monotherapy is superior to lopinavir\/ritonavir in treating COVID-19 https:\/\/www.journalofinfection.com\/article\/S0163-4453(20)30188-2\/pdf In the present study, the authors anayzed&nbsp; the efficacy and safety of lopinavir\/ritonavir and arbidol monotherapy in patients with COVID-19. On day 14 after the admission, no viral load was&hellip; <span class=\"read-more-span\"><a href=\"https:\/\/nclinnovations.org\/covid19monitor\/14-april-2020-umifenovir-arbidol-shorter-duration-of-positive-rna-test\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;(14 April 2020)- Umifenovir (Arbidol)- shorter duration of positive RNA test&#8221;<\/span> <span class=\"genericon genericon-next\"><\/span><\/a><\/span><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"bgseo_title":"","bgseo_description":"","bgseo_robots_index":"index","bgseo_robots_follow":"follow"},"categories":[4,15],"tags":[47,46],"_links":{"self":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/102"}],"collection":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/comments?post=102"}],"version-history":[{"count":3,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/102\/revisions"}],"predecessor-version":[{"id":105,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/102\/revisions\/105"}],"wp:attachment":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/media?parent=102"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/categories?post=102"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/tags?post=102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}